Thailand
Search
Sign In
Product Highlight - Firazyr
30 Nov 2021
Active ingredient: Icatibant acetate.
Indication: Symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults, adolescents & children aged ≥2 years, w/ C1-esterase-inhibitor deficiency.
Dosage & Administration: 30 mg as single subcutaneous injection.
Indication: Symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults, adolescents & children aged ≥2 years, w/ C1-esterase-inhibitor deficiency.
Dosage & Administration: 30 mg as single subcutaneous injection.